Researchers at the Indian Institute of Science (IISc) in Bengaluru have developed an indigenous AI-powered diabetes-care system called SugarSight. The project combines an artificial intelligence-based diabetes platform with a low-cost artificial pancreas system designed for use in India.
A key focus of the effort is affordability. According to the available details, the team is aiming to bring the cost down to about ₹2 lakh, a move that could make advanced diabetes technology more accessible to more patients compared with higher-priced options.
The development is notable because it brings together AI-driven care and a homegrown medical device approach under one system. By building the technology locally, the IISc team is also targeting a major gap in access to diabetes management tools in the Indian market.
SugarSight reflects a broader push toward indigenous healthcare innovation that is built for local needs and price realities. If the cost target is achieved, the system could mark an important step in widening access to advanced diabetes care in India.
